Global Diabetes Management Devices Market Report 2017: Top Selling Products, As Well As Emerging New Products, Including Novel And Potentially Disruptive Technologies - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Diabetes Management Devices Market" report to their offering.

The global market for diabetes management devices - valued at more than $9bn in 2015 - is a substantial, highly competitive market driven by highly sophisticated, evolving technology, particularly in the insulin pump/artificial pancreas and CGM area.

The diabetes management devices market, as covered by the scope of this report, includes sales of (self-monitoring) blood glucose meters, disposable glucose meter test strips and lancets, CGM systems and disposables/sensors/accessories, insulin pumps and various consumable pump supplies (such as insulin cartridges/reservoirs and insulin pump infusion sets, which are frequently replaced), accessories (eg cases/belt clips), as well as diabetes management software.

The report provides the following useful information:

- Diabetes overview

- Key statistics on diabetes prevalence in major regions in the world

- Medical device product portfolios offered by leading manufacturers

- Top selling products, as well as emerging new products, including novel and potentially disruptive technologies

- In-depth market and competitive analysis

Medical devices covered in this report include:

- Glucose monitoring devices (used for self-monitoring of glucose), and continuous glucose monitoring (CGM) systems

- Insulin pump systems

- Artificial pancreas systems

Key Topics Covered:

Executive Summary

1. Overview of Diabetes

2. Glucose Monitoring Devices

3. Insulin Pumps and Emerging Insulin Delivery Devices

4. Artificial Pancreas and Emerging/Competing Technologies

5. Global Diabetes Management Devices Market

Companies Mentioned

- Abbott Laboratories

- Animas Corporation

- Arkray USA

- Ascensia Diabetes Care Holdings AG

- Beta Bionics

- Bigfoot Biomedical

- Bionime USA Corporation

- Cellnovo Group

- Dexcom, Inc.

- F. Hoffman-LaRoche, Ltd. (Roche)

- IBM Watson Health

- iHealth Labs, Inc.

- Insulet Corporation

- LifeScan/Johnson & Johnson

- Medtronic plc

- Nemaura Medical

- Nova Biomedical/Nova Diabetes Care plc

- Panasonic Healthcare Co., Ltd.

- Prodigy Diabetes Care, LLC

- Senseonics

- Tandem Diabetes Care

- Trividia Health

- TypeZero Technologies, LLC

- Verily Life Sciences

For more information about this report visit http://www.researchandmarkets.com/research/z8lwbd/global_diabetes

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diabetes Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diabetes Devices